Shandong Wit Dyne Health Co.,Ltd.

000915

CNE000000Z28

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
35.74 ^CNY	+0.06%		+1.25%	+23.41%

Apr. 17	Shandong Wit Dyne Health Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 18	Shandong Wit Dyne Health Co.,Ltd. Proposes Final Cash Dividend for the Year 2023	CI

Shandong Shanda Wit Science and Technology Co., Ltd.(XSEC:000915) added to S&P Global BMI Index

September 19, 2022 at 12:00 am EDT

Latest news about Shandong Wit Dyne Health Co.,Ltd.

Shandong Wit Dyne Health Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 17	CI
Shandong Wit Dyne Health Co.,Ltd. Proposes Final Cash Dividend for the Year 2023	Mar. 17	CI
Shandong Wit Dyne Health Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 19	CI
WIT Dyne Health Unit's Epalrestat Tablets Passes Regulator's Consistency Evaluation	23-10-20	MT
Shandong Wit Dyne Health Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-19	CI
Shandong Wit Dyne Health Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-07	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Approves Cash Dividend for the Year of 2022, Payable on 12 May 2023	23-04-14	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-14	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Proposes Profit Distribution for 2022	23-03-13	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-19	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-19	CI
Shandong Shanda Wit Science and Technology Co., Ltd.(XSEC:000915) added to S&P Global BMI Index	22-09-19	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-04	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Approves Cash Dividend for 2021	22-04-14	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-14	CI
WIT Dyne Health Lifts 2021 Dividend on Double-Digit Earnings Growth	22-03-13	MT
Shandong Shanda Wit Science and Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021	22-03-11	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-18	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-22	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Announces Executive Changes	21-08-18	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Announces 2020 Final Distribution Plan, Payable on 01 June 2021	21-05-25	CI
Shandong Shanda Wit Science and Technology : Wit Dyne Health Adopts New Name	21-04-28	MT
Shandong Shanda Wit Science and Technology Co., Ltd. has Changed its Name to Shandong Wit Dyne Health Co., Ltd	21-04-26	CI
Shandong Shanda Wit Science and Technology Co., Ltd. Approves Dividend for the Year 2020	21-04-23	CI

Chart Shandong Wit Dyne Health Co.,Ltd.

Duration

Period

More charts

Shandong WIT Dyne Health Co Ltd, formerly Shandong Shanda Wit Science and Technology Co Ltd, is a China-based company principally engaged in pharmaceutical and environment protection businesses. The Company manufactures and sells pharmaceutical products, food and supplies for children through its subsidiary. Its environment protection business includes the manufacture and sale of chlorine dioxide equipment and products, flue gas desulfurization services for power plants and energy saving services. The Company is also involved in manufacture of electronic information products, owned property rental, education services and new material business, among others.

Sector

Pharmaceuticals

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shandong Wit Dyne Health Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

35.74

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SHANDONG WIT DYNE HEALTH CO.,LTD.	+23.41%	1.16B
ELI LILLY AND COMPANY	+33.25%	704B
NOVO NORDISK A/S	+28.59%	577B
JOHNSON & JOHNSON	-3.55%	348B
MERCK & CO., INC.	+18.16%	327B
ABBVIE INC.	+4.36%	288B
ASTRAZENECA PLC	+14.81%	234B
NOVARTIS AG	+4.93%	198B
ROCHE HOLDING AG	-9.78%	194B
AMGEN INC.	-3.69%	147B

Other Pharmaceuticals

Shandong Wit Dyne Health Co.,Ltd.

Equities

000915

CNE000000Z28

Pharmaceuticals

Shandong Shanda Wit Science and Technology Co., Ltd.(XSEC:000915) added to S&P Global BMI Index

Latest news about Shandong Wit Dyne Health Co.,Ltd.

Chart Shandong Wit Dyne Health Co.,Ltd.

Company Profile

Income Statement Evolution

Ratings for Shandong Wit Dyne Health Co.,Ltd.

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals